Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue

skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Healthcare Professional Verification

This section contains medical information for licensed healthcare professionals only. Please confirm your professional status to continue.

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

This webinar is presented in English.

Publié: 2/19/2024 | Modifié: 8/10/2026

Abstract

External quality assessment is an established component of quality assurance in laboratory medicine but a high level, educational EQA programme provides far more to the laboratory than the fulfilment of the requirements of ISO15189.  Each exercise is a learning opportunity and gives an opportunity to examine patterns of laboratory practice. This webinar will use EQA data and a selection of EQA case studies to illustrate how EQA provides a collective benefit in haemoglobinopathy testing beyond the identification of the individual out-of-consensus laboratory.

Attendance at this webinar will support the following learning outcomes:

  1. An understanding of the limitations of the technologies in use in haemoglobinopathy testing
  2. An understanding of how EQA can assist in the implementation of haemoglobinopathy screening guidelines.
  3. A demonstration of the educational opportunities at the heart of haemoglobinopathy EQA

What will you learn?

  • Understanding the Limitations of Haemoglobinopathy Testing Technologies

    Learn about the strengths and limitations of the analytical technologies commonly used in haemoglobinopathy screening and diagnosis.

  • Using EQA to Support Screening Best Practices

    Discover how External Quality Assessment (EQA) programs help laboratories implement haemoglobinopathy screening guidelines and improve testing quality.

  • The Educational Value of EQA Case Studies

    Explore real-world EQA data and case studies that highlight learning opportunities, promote consistency in laboratory practice, and enhance diagnostic performance.

Good EQA or proficiency testing is more than just an annual tick-box exercise, especially in a complex specialty such as hemoglobinopathies.
Dr Barbara De la Salle, Director, UK NEQAS Hematology - Watford - UK

About Dr Barbara De la Salle

Barbara De la Salle is a consultant clinical scientist and Director of the UK NEQAS Haematology external quality assessment scheme.  Before joining UK NEQAS in 2001, she worked for many years in a clinical laboratory, first in general haematology and later developing her long term career interest in the the laboratory diagnosis of inherited red cell disorders at St Bartholomew’s and the Royal London Hospitals in Central London. She is President Elect of the UK NEQAS Charity and a Board Member of the International Society for Laboratory Haematology.

Dr Barbara De la Salle

Test associated with this resource

Deepen your expertise with additional webinars

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis